Modis Therapeutics Competitors and Similar CompaniesClear all
Amicus Therapeutics's competitors and similar companies include Bluebird Bio and VCANBIO.
 Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  VCANBIO VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products. | ||
Founding Date | Founding Date 2002 | Founding Date 1992 | Founding Date 1993 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Somerville, US HQ | Locations Tianjin, CN HQ |
Employees | Employees 58415% increase | Employees 32338% decrease | Employees 2,0149% decrease |
Valuation ($) | Valuation ($) 3.4 b | Valuation ($) 95.4 m | Valuation ($) 1.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) $634.2m (FY, 2025) | Revenue (est.) $83.8m (FY, 2024) | Revenue (est.) ¥1.4b (FY, 2025) |
Cost of goods | Cost of goods $72.9m (FY, 2025) | Cost of goods $89.4m (FY, 2024) | Cost of goods ¥438.8m (FY, 2025) |
Gross profit | Gross profit $561.3m (FY, 2025) | Gross profit ($5.6m) (FY, 2024) | Gross profit ¥993.4m (FY, 2025) |
Net income | Net income ($27.1m) (FY, 2025) | Net income ($240.7m) (FY, 2024) | Net income ¥103.5m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 88m | Total funding raised $ 409m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Bluebird Bio
HQ
Somerville, US
Employees
323↓ 38% decrease
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
View companyVCANBIO
HQ
Tianjin, CN
Employees
2,014↓ 9% decrease
VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products.
View company